FDA Advisory Panel Supports NeuroPace’s RNS Neurostimulator
This article was originally published in The Pink Sheet Daily
Executive Summary
Neurological devices panel votes in favor of device intended to reduce epileptic seizures, despite lingering questions about the trial results.